8-KEarnings & ResultsExhibits & Filings

VERTEX PHARMACEUTICALS INC / MA 8-K Report, Financial Results (Apr 21, 2008)

Filed April 21, 2008For Securities:VRTX

Summary

Vertex Pharmaceuticals Inc. (VRTX) filed an 8-K on April 21, 2008, to report its financial results for the quarter ended March 31, 2008. The primary purpose of this filing is to incorporate by reference a press release issued on the same date that details these financial outcomes. Investors can find the comprehensive details of the company's performance for the first quarter of 2008 within this attached press release (Exhibit 99.1). While the 8-K itself does not contain the specific financial figures, it serves as a formal notification of their release. Investors seeking to understand Vertex's operational and financial condition as of the end of March 2008 should refer to the press release for key metrics such as revenue, earnings, and any significant business updates or guidance provided by the company. The filing ensures these results are publicly accessible and formally documented.

Key Highlights

  • 1Vertex Pharmaceuticals Inc. (VRTX) filed an 8-K on April 21, 2008.
  • 2The report announces the company's financial results for the quarter ended March 31, 2008.
  • 3The press release containing the detailed financial results is attached as Exhibit 99.1 and incorporated by reference.
  • 4Investors are directed to the press release for specific financial performance data and operational updates.
  • 5The filing confirms the public disclosure of Q1 2008 financial information.
  • 6The information in the press release is not deemed 'filed' for Section 18 liability purposes unless expressly incorporated into other filings.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce and incorporate by reference Vertex Pharmaceuticals' press release detailing its consolidated financial results for the quarter ended March 31, 2008.

The specific financial results for the quarter ended March 31, 2008, are contained in the press release attached to this 8-K as Exhibit 99.1. Investors should refer to this press release for detailed financial information.

No, the 8-K filing itself does not contain the detailed financial numbers. It serves as a notification and includes the press release (Exhibit 99.1) which contains those specific figures and performance details.

The information set forth in the press release (Exhibit 99.1) is generally not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it's not subject to the liability of that section, unless Vertex expressly incorporates it by reference into another SEC filing.